These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 395959)

  • 21. [Brazilian multicenter study of sotalol effectiveness in ventricular arrhythmias].
    Maia IG; Lorga AM; de Paola AA; Rassi A; Perez AK; Sobral D; Atie J; Gizzi JC; Darwich R
    Arq Bras Cardiol; 1996 Mar; 66(3):173-8. PubMed ID: 8762699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of antihiasthenic syndromes (with creatinol-O-phosphate)].
    Madrid Arráu J; López Onega P; Arroyo M; Cacho Rodero A
    Rev Clin Esp; 1976 Sep; 142(6):517-20. PubMed ID: 792963
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of creatinol-O-phosphate on left ventricular function in coronary disease patients].
    Cucchini F; Colla B; Di Donato M; Visioli O
    Boll Soc Ital Cardiol; 1978; 23(3):527-32. PubMed ID: 572691
    [No Abstract]   [Full Text] [Related]  

  • 24. An analysis of the reduction by creatinol O-phosphate of the myocardial lesions evoked by isoprenaline in the rat.
    Godfraind T; Sturbois X
    Arzneimittelforschung; 1979; 29(9a):1457-64. PubMed ID: 575492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbon monoxide exposure of subjects with documented cardiac arrhythmias.
    Chaitman BR; Dahms TE; Byers S; Carroll LW; Younis LT; Wiens RD
    Res Rep Health Eff Inst; 1992 Sep; (52):1-26; discussion 27-37. PubMed ID: 1418771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of creatinol-O-phosphate (COP) on haemodynamics and cardiac metabolism in conscious and anaesthetized dogs.
    Marchetti G; Merlo L
    Arzneimittelforschung; 1978; 28(10):1708-11. PubMed ID: 582673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A clinical study of bonnecor in the treatment of heart rhythm disorders in patients with ischemic heart disease].
    Gorshkov VA; Solodukhina IS; Kesarev GV; Kurakina TI; Solov'eva FV
    Sov Med; 1991; (7):45-7. PubMed ID: 1948344
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of mexiletine in chronic ventricular arrhythmias: a multicentre double-blind medium-term trial.
    Poggesi L; Scarti L; Ieri A; Lanzetta T; Grazzini M; Del Bene P; Masini G; Del Citerna F; Carnovali M; Masotti G
    Int J Clin Pharmacol Res; 1989; 9(4):269-75. PubMed ID: 2476406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias.
    Van Durme JP
    Acta Cardiol Suppl; 1980; (25):121-5. PubMed ID: 6990664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Circadian variation in complex ventricular arrhythmias in patients with coronary disease].
    Dejlanin-Ilić M; Ilić S
    Srp Arh Celok Lek; 1992; 120(3-4):89-92. PubMed ID: 1465665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized double blind trial comparing sotalol and propranolol in chronic ventricular arrhythmia.
    Kubac G; Klinke WP; Grace M
    Can J Cardiol; 1988 Oct; 4(7):355-9. PubMed ID: 3067834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ventricular arrhythmias in mitral valve disease: incidence, severity and relations to hemodynamic parameters].
    von Olshausen K; Treese N; Schwarz F; Kübler W; Meyer J
    Z Kardiol; 1986 Apr; 75(4):196-201. PubMed ID: 3727658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of tocainide and prajmalium bitartrate for the treatment of ventricular arrhythmias.
    Schwartzkopff B; Schilling G; Simon H
    Arzneimittelforschung; 1983; 33(1):153-8. PubMed ID: 6403021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International Mexiletine and Placebo Antiarrhythmic Coronary Trial (IMPACT): II. Results from 24-hour electrocardiograms. IMPACT Research Group.
    Eur Heart J; 1986 Sep; 7(9):749-59. PubMed ID: 3533546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of patients at risk for sudden heart death by long-term ECG. The role of life-threatening ventricular arrhythmias].
    Hombach V; Höpp HW; Osterspey A; Winter U; Deutsch H; Hilger HH
    Herz; 1984 Feb; 9(1):6-25. PubMed ID: 6200415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intravenous nitroglycerin infusion suppresses exercise-induced arrhythmia in patients with ischemic cardiopathy: indications for chronic treatment ].
    Bonetti F; Margonato A; Mailhac A; Vicedomini G; Cianflone D; Scarpazza P; Chierchia SL
    Cardiologia; 1990 May; 35(5):401-6. PubMed ID: 2125240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of Bonnecor on clinical manifestations, bioelectric cardiac activity and cardiac hemodynamics in patients with acute myocardial infarction and chronic ischemic heart disease].
    Ol'binskaia LI; Rybakov MA; Sizova ZhM
    Klin Med (Mosk); 1990 Feb; 68(2):44-6. PubMed ID: 2335944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-related antiarrhythmic effects of nicainoprol in patients with chronic ventricular arrhythmias--a double-blind, placebo-controlled, cross-over multicentre trial. Nicainoprol Study Group.
    Schneider W; Reifart N; Blaeser A; Ostrowski J; Kaltenbach M; Kober G
    Eur Heart J; 1991 Aug; 12(8):900-8. PubMed ID: 1915428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High dose caffeine and ventricular arrhythmias.
    Myers MG; Harris L
    Can J Cardiol; 1990 Apr; 6(3):95-8. PubMed ID: 1692755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.